These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1911845)

  • 1. Purification of the proteinase from group B streptococci that inactivates human C5a.
    Bohnsack JF; Zhou XN; Williams PA; Cleary PP; Parker CJ; Hill HR
    Biochim Biophys Acta; 1991 Aug; 1079(2):222-8. PubMed ID: 1911845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial evasion of the antibody response: human IgG antibodies neutralize soluble but not bacteria-associated group B streptococcal C5a-ase.
    Bohnsack JF; Zhou XN; Gustin JN; Rubens CE; Parker CJ; Hill HR
    J Infect Dis; 1992 Feb; 165(2):315-21. PubMed ID: 1730898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal species.
    Bohnsack JF; Chang JK; Hill HR
    Infect Immun; 1993 Apr; 61(4):1421-6. PubMed ID: 8454345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus.
    Bohnsack JF; Mollison KW; Buko AM; Ashworth JC; Hill HR
    Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):635-40. PubMed ID: 1996961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
    Hill HR; Bohnsack JF; Morris EZ; Augustine NH; Parker CJ; Cleary PP; Wu JT
    J Immunol; 1988 Nov; 141(10):3551-6. PubMed ID: 3053900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections.
    Bohnsack JF; Widjaja K; Ghazizadeh S; Rubens CE; Hillyard DR; Parker CJ; Albertine KH; Hill HR
    J Infect Dis; 1997 Apr; 175(4):847-55. PubMed ID: 9086140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of group B streptococcus scpB alter functional activity of a cell-associated peptidase that inactivates C5a.
    Bohnsack JF; Takahashi S; Hammitt L; Miller DV; Aly AA; Adderson EE
    Infect Immun; 2000 Sep; 68(9):5018-25. PubMed ID: 10948119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similarity between the group B and A streptococcal C5a peptidase genes.
    Cleary PP; Handley J; Suvorov AN; Podbielski A; Ferrieri P
    Infect Immun; 1992 Oct; 60(10):4239-44. PubMed ID: 1398935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of C5a-ase in group B streptococcal resistance to opsonophagocytic killing.
    Takahashi S; Nagano Y; Nagano N; Hayashi O; Taguchi F; Okuwaki Y
    Infect Immun; 1995 Dec; 63(12):4764-9. PubMed ID: 7591133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsular sialic acid limits C5a production on type III group B streptococci.
    Takahashi S; Aoyagi Y; Adderson EE; Okuwaki Y; Bohnsack JF
    Infect Immun; 1999 Apr; 67(4):1866-70. PubMed ID: 10085029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunization in mice against group B streptococci using encapsulated C5a peptidase.
    Santillan DA; Andracki ME; Hunter SK
    Am J Obstet Gynecol; 2008 Jan; 198(1):114.e1-6. PubMed ID: 17905172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial genetics and human immunity to group B streptococci.
    Adderson EE; Takahashi S; Bohnsack JF
    Mol Genet Metab; 2000; 71(1-2):451-4. PubMed ID: 11001839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcal C5a peptidase is a highly specific endopeptidase.
    Cleary PP; Prahbu U; Dale JB; Wexler DE; Handley J
    Infect Immun; 1992 Dec; 60(12):5219-23. PubMed ID: 1452354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservation of the C5a peptidase genes in group A and B streptococci.
    Chmouryguina I; Suvorov A; Ferrieri P; Cleary PP
    Infect Immun; 1996 Jul; 64(7):2387-90. PubMed ID: 8698456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional similarity of C5a-ase enzymes from group A and B streptococci.
    Chmouryguina II; Suvorov AN; Carlson B; Cleary P
    Adv Exp Med Biol; 1997; 418():757-9. PubMed ID: 9331762
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of novel adhesins from Group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding.
    Beckmann C; Waggoner JD; Harris TO; Tamura GS; Rubens CE
    Infect Immun; 2002 Jun; 70(6):2869-76. PubMed ID: 12010974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulent human strains of group G streptococci express a C5a peptidase enzyme similar to that produced by group A streptococci.
    Cleary PP; Peterson J; Chen C; Nelson C
    Infect Immun; 1991 Jul; 59(7):2305-10. PubMed ID: 2050400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo Streptococcus pyogenes C5a peptidase activity: analysis using transposon- and nitrosoguanidine-induced mutants.
    O'Connor SP; Cleary PP
    J Infect Dis; 1987 Sep; 156(3):495-504. PubMed ID: 3039012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity interaction between fibronectin and the group B streptococcal C5a peptidase is unaffected by a naturally occurring four-amino-acid deletion that eliminates peptidase activity.
    Tamura GS; Hull JR; Oberg MD; Castner DG
    Infect Immun; 2006 Oct; 74(10):5739-46. PubMed ID: 16988251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of polymeric encapsulated C5a peptidase-based group B streptococcus vaccines in a murine model.
    Santillan DA; Rai KK; Santillan MK; Krishnamachari Y; Salem AK; Hunter SK
    Am J Obstet Gynecol; 2011 Sep; 205(3):249.e1-8. PubMed ID: 21802065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.